Accès ouvert
2024
article
OpenAlex
Luke J. Peppone, Amber S. Kleckner, Chunkit Fung, J. Edward Puzas et autres
BACKGROUND: Androgen deprivation therapy (ADT) inhibits prostate cancer growth. However, ADT causes loss of bone mineral density (BMD) and an increase in fracture risk; effective interventions for ADT-induced bone loss are limited. METHODS: A phase 2 randomized controlled trial investigated the feasibility, …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Collynn F. Woeller, Sydney Lim, Elisa Roztocil, Min Yee et autres
us
(code pays fourni par la source)
2020
article
OpenAlex
Robert B. Conley, Gemma Adib, Robert A. Adler, Kristina Åkesson et autres
Osteoporosis-related fractures are undertreated, due in part to misinformation about recommended approaches to patient care and discrepancies among treatment guidelines. To help bridge this gap and improve patient outcomes, the American Society for Bone and Mineral Research assembled a multistakeholder coalition to …
us
(code pays fourni par la source)
2020
erratum
OpenAlex
Yuchen Wang, Maureen Newman, Marian A. Ackun‐Farmmer, Michael P. Baranello et autres
ADVERTISEMENT RETURN TO ISSUEPREVAdditions and Correc...Additions and CorrectionsNEXTORIGINAL ARTICLEThis notice is a correctionCorrection to Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture HealingYuchen WangYuchen WangMore by Yuchen Wang, Maureen R. NewmanMaureen R. NewmanMore by Maureen R. Newman, Marian Ackun-FarmmerMarian Ackun-FarmmerMore …
2020
article
OpenAlex
Robert B. Conley, Gemma Adib, Robert A. Adler, Kristina Åkesson et autres
Osteoporosis-related fractures are undertreated, due in part to misinformation about recommended approaches to patient care and discrepancies among treatment guidelines. To help bridge this gap and improve patient outcomes, the American Society for Bone and Mineral Research assembled a multistakeholder coalition to …
us, se, au, gb, sk, gr, ca, it
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Robert B. Conley, Gemma Adib, Robert A. Adler, Kristina Åkesson et autres
Osteoporosis-related fractures are undertreated, due in part to misinformation about recommended approaches to patient care and discrepancies among treatment guidelines. To help bridge this gap and improve patient outcomes, the American Society for Bone and Mineral Research assembled a multistakeholder coalition to …
us, sy, se, au, gb, qa, sk, gr, ca, it
(code pays fourni par la source)
2019
book-chapter
OpenAlex
J. Edward Puzas, Brendan F. Boyce
us
(code pays fourni par la source)
2019
paratext
OpenAlex
David Abraham, Maria Cecília Puntel de Almeida, Elena Ambrogini, Andrew Arnold et autres
gb, us, hu, be, ca, it
(code pays fourni par la source)
Accès ouvert
2018
editorial
OpenAlex
J. Edward Puzas
This report, “Mandible exosomal ssc-mir-133b regulates tooth development in miniature swine via endogenous apoptosis” by Li et al. is an important step forward in describing the factors that control tooth development in a large animal model. That many of the regulatory miRNA …
us
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
Luke J. Peppone, Marilyn N. Ling, Alissa Huston, Mary E. Reid et autres
us, br
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Maureen Newman, Steven G. Russell, Christopher S. Schmitt, Ian A. Marozas et autres
Drug delivery to bone is challenging, whereby drug distribution is commonly <1% of injected dose, despite development of several bone-targeted drug delivery systems specific to hydroxyapatite. These bone-targeted drug delivery systems still suffer from poor target cell localization within bone, as at …
us
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Yuchen Wang, Maureen Newman, Marian A. Ackun‐Farmmer, Michael P. Baranello et autres
Despite several decades of progress, bone-specific drug delivery is still a major challenge. Current bone-acting drugs require high-dose systemic administration which decreases therapeutic efficacy and increases off-target tissue effects. Here, a bone-targeted nanoparticle (NP) delivery system for a β-catenin agonist, 3-amino-6-(4-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-N-(pyridin-3-yl)pyrazine-2-carboxamide, a …
us
(code pays fourni par la source)